Key Highlights
● OMNIQ Corp points to a $170 billion border-security spending wave as a major addressable market opportunity for its machine-vision technology.
● The company holds just $787,000 in cash ahead of second-quarter results, a thin position relative to its market ambitions.
● OMNIQ sells machine-vision systems, cameras paired with AI software that read vehicle license plates, positioning it for border-security and public-safety applications.
● The gap between OMNIQ's large addressable market narrative and its small Balance Sheet is the central tension in the Investment case.
OMNIQ Corp. (OTC: OMQS) is a micro-cap where the gap between the story and the balance sheet is the story. The Utah-headquartered company sells machine-vision systems, meaning cameras paired with AI software that read vehicle licence plates and verify parking credentials, to parking operators, hospitals, universities and security agencies.
Its most recent statement, issued 2 June 2026 on a Form 8-K, argued that a wave of US government spending on immigration, border and security infrastructure is expanding the market for that technology. The company has been quiet since: no press releases, no contracts, and no SEC filings beyond one insider Form 4 in late July.
That silence matters with second-quarter results approaching. OMNIQ closed the March quarter with $787,000 of cash, a $14.6 million working-capital Deficit and a going-concern warning from management. Shares near $0.10 give a Market Capitalisation of roughly $1.5 million against annual Revenue of $33 million.
What Happened
The 2 June release was a positioning statement, not a transaction. Citing Wall Street Journal reporting, OMNIQ said roughly $170 billion had been allocated toward immigration and security initiatives, alongside about $165 billion of additional Homeland Security funding for border technology and surveillance infrastructure.
Chief executive and chairman Shai Lustgarten said he was encouraged by the level of investment across the machine-vision industry. The release attached no contract, purchase order or revenue figure. It is a claim about a market, not a booked win.
The genuine commercial news came earlier in 2026. In January, OMNIQ said a Fortune 100 technology company deployed its plate-recognition systems across Silicon Valley campuses. In February, an Ohio hospital network expanded OMNIQ's PERCS permitting and access-control platform to further campuses after two pilots. In March, a hospitality parking operator awarded a proof-of-concept contract for a 28-camera vehicle damage-inspection system on an 86-day plan.
Why It Matters
OMNIQ is a deliberately narrower company than two years ago. In July 2025 it sold its US legacy Business unit, the old Quest distribution operation, to Summit Junction Holdings LLC, removing roughly 63% of pre-sale debt, an estimated $45 million. What remained were the Smart Automation and AI divisions, about $38.5 million of 2024 revenue pro forma.
The logic was to shed low-margin reselling and keep higher-margin sensor-and-software work. On Margin it worked, but the improved profile has not produced positive cash generation, and the deal left a related-party Debt structure that still constrains the company's options. Permit verification synced to HR databases also carries ongoing service revenue rather than one-off hardware sales, a more durable base if OMNIQ can fund the installations.
The Numbers
For full-year 2025, reported 15 April 2026, revenue was $33.0 million, down about 5.5%. Gross Profit rose 60.5% to $9.0 million and gross margin widened to 27% from 16.1%. The net loss collapsed to $137,000 from $10.0 million, flattered by an accounting gain the company estimated at roughly $35 million from the legacy-unit sale.
The Annual Report told the harder version. Cash fell to $679,000 at 31 December 2025 from $2.3 million, the stockholders' deficit stood at $12.7 million and the accumulated deficit at $124.1 million. Management disclosed substantial doubt about the company's ability to continue as a going concern. In December 2025 OMNIQ raised roughly $941,000 net in equity, including $150,000 from Lustgarten.
First-quarter 2026, reported 20 May, showed margins holding but the loss widening. Revenue was $7.68 million, down 3.8%, while gross profit edged up 3.3% to $2.255 million. Operating loss expanded to $1.2 million from $425,000 and the net loss was $1.65 million, or $0.11 per share.
The debt stack is unusual for this size: about $5.62 million of related-party advances, a $9.4 million related-party note tied to the Quest sale, and roughly $5.1 million of Israeli bank loans from Bank Leumi and Bank Hapoalim, pushed into current liabilities by failed covenants.
What It Means for the Company
OMNIQ has traded scale for focus, and the market has not paid for it. A business generating $33 million of revenue and $9 million of gross profit valued near $1.5 million is the Equity market saying Enterprise value sits almost entirely with creditors.
Recent Capital came from insiders and related parties rather than institutional markets, and in July 2026 the board granted Lustgarten, who is chief executive, chairman and interim chief financial officer, an option over 250,000 shares at $0.144. The combined roles are a governance point investors typically flag. One positive: no customer exceeded 10% of continuing-operations revenue in 2025 or 2024, so concentration risk is low.
Risks Investors Should Watch
The going-concern disclosure dominates, appearing in both the 2025 annual report and the first-quarter 2026 filing. Covenant breaches have already reclassified the Israeli bank debt as current, meaning lenders could press for repayment the company cannot fund from $787,000 of cash.
Dilution is live. At a sub-$0.15 share price any meaningful equity raise would be heavily dilutive, and recent raises depended on insider participation.
Revenue is declining and the first-quarter operating loss nearly tripled year on year. OMNIQ's 2024 departure from Nasdaq, for failing the exchange's $35 million market-value requirement, leaves it on OTC Markets with thin Liquidity and no analyst coverage.
What Comes Next
The next hard catalyst is second-quarter 2026 results and the Form 10-Q. No confirmed date has been published; third-party trackers point to the second half of August, and last year OMNIQ filed its second-quarter 10-Q on 15 August 2025. Three things matter more than the revenue headline: closing cash, whether the operating loss narrows toward the near-breakeven 2025 exit rate, and whether the covenant breaches have been waived.
Beyond that, watch for conversion of the 86-day proof of concept into a paid rollout, further Ohio hospital expansions, and any concrete border-security order that would substantiate the June thesis. OMNIQ said in 2024 it intended to seek relisting on a national exchange; nothing since indicates progress.
A Big Market Opportunity, A Small Balance Sheet
OMNIQ has a real product portfolio, named Blue-Chip and institutional deployments, and a materially better gross margin than two years ago. It has also told investors twice in four months that it may not be able to continue as a going concern.
The June statement about $170 billion of border and security funding describes an opportunity, not an order book, and nothing has been announced since. Until the second-quarter numbers show cash stabilising and the covenant position resolved, OMQS remains a distressed micro-cap where the balance sheet, not the technology, sets the terms.






Please wait processing your request...